Document is current
Any future updates will be listed below
-
Authors
Narendra, Varun K.
Das, Tandrila
Wierciszewski, Linsey J.
Londoner, Rebecca J.
Morrison, Joshua K. https://orcid.org/0000-0003-4174-6338
Martindale, Pia
Devine, Tessa
Chen, Kevin
Trombetta, Michael https://orcid.org/0009-0006-9661-2221
Kanno, Yuzuka https://orcid.org/0000-0002-8375-3328
Casiano, Alejandro E.
de Stanchina, Elisa
Lareau, Caleb A. https://orcid.org/0000-0003-4179-4807
Lowe, Scott W. https://orcid.org/0000-0002-5284-9650
Gitlin, Alexander D. https://orcid.org/0000-0002-9229-0919
- License Information
-
More Information
Article History
Received: 17 May 2024
Accepted: 27 October 2025
First Online: 3 November 2025
Competing interests
: A.D.G. is a consultant for Genentech. While not directly related to this manuscript, S.W.L. declares outside consultancy and equity for Oric Pharmaceuticals, Blueprint Medicines, Mirimus, Senecea Therapeutics, Faeth Therapeutics and PMV Pharmaceuticals; and outside consultancy (no equity) for Fate Therapeutics. C.A.L. is a consultant to Cartography Biosciences. The other authors declare no competing interests.
